81,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
41 °P sammeln
  • Gebundenes Buch

Merck and the pharmaceutical industry are headline news. Roy Vagelos, former CEO of Merck, highlights his efforts to turn around the Merck laboratories and introduce an entirely novel approach to drug development. He and his co-author explain where and why he failed and carefully analyze where he succeeded.

Produktbeschreibung
Merck and the pharmaceutical industry are headline news. Roy Vagelos, former CEO of Merck, highlights his efforts to turn around the Merck laboratories and introduce an entirely novel approach to drug development. He and his co-author explain where and why he failed and carefully analyze where he succeeded.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
P. Roy Vagelos is retired Chairman of Merck and Co., Inc.; Chairman of Regeneron Pharmaceuticals Inc.; and Chairman of Theravance Corporation.